search

Active clinical trials for "Hypertension"

Results 3111-3120 of 5863

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Pulmonary Hypertension

The purpose of this study is to evaluate the safety and effectiveness of tadalafil for the treatment of pulmonary arterial hypertension.

Completed15 enrollment criteria

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan....

Hypertension

The primary objective of this study is to compare the effectiveness of telmisartan 80 mg / hydrochlorothiazide 25 mg [Micardis HCT] to valsartan 160 mg / hydrochlorothiazide 25 mg [Diovan HCT] and placebo in the treatment of Stage 1 and Stage 2 hypertension.

Completed23 enrollment criteria

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular...

Open-angle GlaucomaOcular Hypertension

The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.

Completed6 enrollment criteria

Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension

Pulmonary Hypertension

OBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.

Completed36 enrollment criteria

Treatment of Hypertension With Two Exercise Intensities

Hypertension

To determine whether exercise training could significantly replace medication as a treatment for mild essential hypertension.

Completed1 enrollment criteria

Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And...

Hypertension

Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure

Completed6 enrollment criteria

Potential Risk Factors for Stroke

Carotid AtherosclerosisCerebrovascular Accident3 more

Early studies have shown that the immune system may play a role in the development of strokes. Conditions such as high blood pressure, high cholesterol, diabetes, and old age can activate the immune system and increase the risk of developing hardening of the arteries (atherosclerosis) and damaged blood vessels. Researchers will attempt to characterize factors that may contribute to atherosclerosis and stroke by measuring certain components of the immune system, cytokines and leukocyte activation. Measurements will be taken from patients that are considered to be stroke prone and from patients without risk factors for the development of stroke. Researchers will measure the immune system components at the beginning of the study, at six months, and at the one-year completion of the study. The study will attempt to determine; I) If patients with risk factors for stroke have an increased activation of the immune system II) If patients with risk factors for stroke that are symptomatic have higher levels of immune system activation compared to patients who do not have symptoms III) If patients with increased activation of the immune system have accelerated hardening of the arteries (atherosclerosis)

Completed7 enrollment criteria

Dietary Approaches to Stop Hypertension (DASH)

Cardiovascular DiseasesHeart Diseases2 more

To test the effectiveness of dietary patterns in lowering blood pressure.

Completed1 enrollment criteria

Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)

Cardiovascular DiseasesHeart Diseases2 more

The SHEP Pilot Study had six objectives, each designed to develop and test critical components of a full scale trial directed at the health consequences of treating isolated systolic hypertension (ISH) in the elderly. l. To estimate and compare the yield of participants for randomization into a clinical trial from various community groups using various recruitment techniques. 2. To estimate compliance with the visit schedule and to the prescribed double-blind regimens. 3. To estimate and compare the effectiveness of specified antihypertensive medications in reducing the blood pressure. 4. To estimate and compare the unwanted effects of specified antihypertensive medication in an elderly population. 5. To evaluate the feasibility and effectiveness of periodic behavioral assessment in this population. 6. To develop and test methods of ascertaining stroke and other disease endpoints.

Completed1 enrollment criteria

Polyunsaturates and KCL to Control Mild Hypertension

Cardiovascular DiseasesHeart Diseases2 more

To test the efficacy of omega-3 fatty acids in untreated mild hypertensives and magnesium, calcium, and potassium supplementation supplementation in non-hypertensives. These clinical trials were conducted in sequence over a four year period.

Completed1 enrollment criteria
1...311312313...587

Need Help? Contact our team!


We'll reach out to this number within 24 hrs